Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

View 0 Studies Requested

Trial Summary

About CDAS Project, PI, Publications: Multiplexed Assay of Serum Biomarkers for Ovarian Cancer

Datasets


Site: Ovary

Inclusion Criteria:

  • Females
  • No Prior History of Any Cancer
  • No Report of Bilateral Oophorectomy
  • Exclude LMPs and Reported Cancers

Matching Factors:

  • Age at Serum Draw (5 years)
  • Year of Serum Draw

Match Ratio: 4:1 for general controls, 2:1 for controls who ever had an elevated CA-125, and 2:1 for controls who have a family history of breast or ovarian cancer

Match Technique: Frequency matching only non-cases as controls.


Analytes:

  • A Disintegrin and Metalloproteinase With a Thrombospondin Type 1 Motif, Member 13
  • AGRP
  • Aldehyde Dehydrogenase 1 Family, Member A1
  • Alpha-1 Antitrypsin
  • Alpha-1-Acid Glycoprotein 1
  • Alpha-2-Heremans-Schmid Glycoprotein
  • Ankyrin Repeat Domain 63
  • Anti-4B7 IgG Autoantibody
  • Anti-4B7 IgM Autoantibody
  • Anti-ARID1A IgG Autoantibody
  • Anti-ARID1A IgM Autoantibody
  • Anti-CA-125 IgG Autoantibody
  • Anti-CA-125 IgM Autoantibody
  • Anti-CK 19 IgG Autoantibody
  • Anti-CK 19 IgM Autoantibody
  • Anti-Cancer/Testis Antigen 1A IgG Autoantibody
  • Anti-Cancer/Testis Antigen 1A IgM Autoantibody
  • Anti-HARS IgG Autoantibody
  • Anti-HARS IgM Autoantibody
  • Anti-HE4 IgG Autoantibody
  • Anti-HE4 IgM Autoantibody
  • Anti-HRAS IgG Autoantibody
  • Anti-HRAS IgM Autoantibody
  • Anti-IL-8 IgG Autoantibody
  • Anti-IL-8 IgM Autoantibody
  • Anti-KRAS IgG Autoantibody
  • Anti-KRAS IgM Autoantibody
  • Anti-LDHA IgG Autoantibody
  • Anti-LDHA IgM Autoantibody
  • Anti-OVX1 IgG Autoantibody
  • Anti-OVX1 IgM Autoantibody
  • Anti-PDGF-BB IgG Autoantibody
  • Anti-PDGF-BB IgM Autoantibody
  • Anti-SURV IgG Autoantibody
  • Anti-SURV IgM Autoantibody
  • Anti-T71-2A IgG Autoantibody
  • Anti-T71-2A IgM Autoantibody
  • Anti-TP53 IgG Autoantibody
  • Anti-TP53 IgM Autoantibody
  • Anti-UCHL1 IgG Autoantibody
  • Anti-UCHL1 IgM Autoantibody
  • Anti-VEGF IgG Autoantibody
  • Anti-VEGF IgM Autoantibody
  • Anti-c-Myc IgG Autoantibody
  • Anti-c-Myc IgM Autoantibody
  • Anti-p53 IgG Autoantibody
  • Anti-p53 IgM Autoantibody
  • Apolipoprotein A-I
  • Apolipoprotein A-II
  • Apolipoprotein B
  • Apolipoprotein C-II
  • Apolipoprotein C-III
  • Apolipoprotein E
  • C-Reactive Protein
  • Cancer Antigen 125
  • Carcinoembryonic antigen
  • Chemokine
  • Chr7_422_10(012)
  • Chromosome X Open Reading Frame 21
  • Clusterin
  • Collagen, Type I, Alpha 1
  • Complement Component 9
  • Complement Factor D
  • Cytokeratin
  • Eotaxin
  • Epidermal Growth Factor Receptor
  • Fibrinogen
  • Fibroblast Activation Protein-alpha
  • Follicle Stimulating Hormone
  • Galectin-3
  • Growth Hormone
  • Hemopexin
  • Interleukin-2 Receptor 
  • Lumican
  • Macrophage Migration Inhibitory Factor
  • Matrix Metalloproteinase-2
  • Matrix Metalloproteinase-3
  • Melanoma inhibitory activity
  • Melanoma-Associated Antigen C1
  • Neural Cell Adhesion Molecule
  • Paraoxonase 1
  • Platelet-Derived Growth Factor-AA
  • Prolactin
  • Pulmonary and Activation-Regulated Chemokine
  • Retinol-Binding Protein 4
  • SCGB1A1
  • Soluble FAS
  • Soluble FAS Ligand
  • Soluble Vascular Cell Adhesion Molecule 1
  • Thyroid-Stimulating Hormone
  • Tissue Plasminogen Activator Inhibitor-1
  • Transferrin
  • Transthyretin
  • Tumor Protein P53
  • Vascular Adhesion Protein
  • Vitamin D Binding Protein
  • X-Ray Induced P53-dependent #1

Number of Cases: 119

Number of Controls: 952